These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9136912)
1. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease. Blann AD; Davis A; Miller JP; McCollum CN Am J Hematol; 1997 May; 55(1):15-23. PubMed ID: 9136912 [TBL] [Abstract][Full Text] [Related]
2. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor. Blann AD; Goode GK; Miller JP; McCollum CN Blood Coagul Fibrinolysis; 1997 Apr; 8(3):200-4. PubMed ID: 9167022 [TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Blann AD; Waite MA Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446 [TBL] [Abstract][Full Text] [Related]
4. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. Blann AD; Miller JP; McCollum CN Atherosclerosis; 1997 Jul; 132(2):151-6. PubMed ID: 9242960 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of the TGF-beta receptor are increased in atherosclerosis. Blann AD; Wang JM; Wilson PB; Kumar S Atherosclerosis; 1996 Feb; 120(1-2):221-6. PubMed ID: 8645363 [TBL] [Abstract][Full Text] [Related]
7. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416 [TBL] [Abstract][Full Text] [Related]
8. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Freestone B; Chong AY; Nuttall S; Lip GY Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280 [TBL] [Abstract][Full Text] [Related]
9. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. Blann AD; Tse W; Maxwell SJ; Waite MA J Hypertens; 1994 Aug; 12(8):925-8. PubMed ID: 7529277 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653 [TBL] [Abstract][Full Text] [Related]
11. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785 [TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Blann AD; Seigneur M; Steiner M; Boisseau MR; McCollum CN Eur J Clin Invest; 1997 Nov; 27(11):916-21. PubMed ID: 9395787 [TBL] [Abstract][Full Text] [Related]
14. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Ferri C; Desideri G; Baldoncini R; Bellini C; De Angelis C; Mazzocchi C; Santucci A Diabetes; 1998 Apr; 47(4):660-7. PubMed ID: 9568701 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients]. Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986 [TBL] [Abstract][Full Text] [Related]
16. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054 [TBL] [Abstract][Full Text] [Related]
17. Endothelial activation markers soluble E-selectin and von Willebrand factor in primary hyperparathyroidism. Lumachi F; Zanella S; Cella G; Casonato A; Fallo F In Vivo; 2011; 25(2):279-82. PubMed ID: 21471547 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715 [TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Blann AD; Dobrotova M; Kubisz P; McCollum CN Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997 [TBL] [Abstract][Full Text] [Related]
20. Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Moss M; Gillespie MK; Ackerson L; Moore FA; Moore EE; Parsons PE Crit Care Med; 1996 Nov; 24(11):1782-6. PubMed ID: 8917025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]